Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/pathophysiology-risk-factors-and-management-of-chronic-heart-failure-volume-2/descriptif_4666958
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4666958

0 article 

 Frais de port 0,01€*

Exclusivité web : à partir de 35 euros d’achat, frais de port à 1 centime pour les expéditions vers la France métropolitaine, la Suisse et l’UE avec Colissimo ou GLS

Pathophysiology, Risk factors and Management of Chronic Heart Failure, Volume 2

Langue : Anglais

Coordonnateurs : Singh Ram B., Fedacko Jan, Hristova Krasimira, Nagib Elkilany Galal Eldin

Pathophysiology, Risk factors and Management of Chronic Heart Failure, Volume 2 is the second of two separate but closely related volumes which aim to provide an inclusive overview on Chronic Heart Failure (CHF).This second volume is focused on the therapies of various kinds, management, guidelines and future advances in heart failure. It explains the uncertainties and issues in pharmacological therapies in CHF, along with a number of new treatment options such as gene therapy, cell implantation therapy, invasive and surgical interventions, and non-pharmacological therapies, which would include dietary interventions, holistic approaches, and physical training. It discusses in depth the management of patients with heart failure, and concludes with detailed and updated guidelines from the International College of Cardiology, as well as future research directions and advances.These 2 separate volumes serve as essential references to both researchers and practicing clinicians, proposing novel methods of research by using behavioural and environmental risk factors as intervention agent, as well as discussing deficiency in the present approaches in management of HF and proposing new methods of early diagnosis and therapies for the clinical management of CHF.

Section 9. Therapies in chronic heart failure1. Pharmacological therapy of chronic heart failure ­2. Management of arrhythmia during heart failure 3. Ivabradine therapy (hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers).4. Therapy in acute heart failure5. Gene Therapy in Heart Failure6. Cell Implantation Therapy in Heart Failure7. Diagnosis and Treatment of Paediatric Heart Failure8. Effects of Hormone Replacement Therapy on Cardiovascular Disease in Postmenopausal Women9. Health Care Burden of Cardiorespiratory Diseases and Heart Failure Caused by Air Pollutants and Microparticles

Section 10. Invasive Therapies in chronic heart failure10. Intra-aortic balloon pumping during heart failure11. Vagal nerve stimulation for treatment of heart failure12. Ventricular assistance - role of CRT13. Cardiac transplantation14. Dialysis and hemofiltration during heart failure15. Pathogenesis and Therapy of the thrombosis in patients with heart failure 16. Surgical Approaches in heart failure

Section 11. Non-pharmacological therapies in heart failure17. Holistic Approaches in the Management of HF18. Nutritional intervention in HF19. Physical training in HF20. Yoga therapy for HF21. Chronic Heart Failure Management in the domiciliary and care home environment and statistical methodology 22. Remote Monitoring of Patients With Biventricular Defibrillators Through the Carelink System Improves the Management of Arrhythmias and Heart Failure Episode

Section 12. Guidelines in CHF23. 2020 Guidelines of the International College of Cardiology for Management of HF24. Future advances in the diagnosis and management of chronic heart failure25. Role of Stalwarts of cardiomyocyte dysfunction and CHF

Dr. Ram B Singh is president of the Tsim Tsoum Insitutute in Krakow, Poland. He's an honorary fellow of the Halberg Chronobiology Centre, a member of the Russian Academy of Medical Sciences, a fellow of the International Academy of Cardiovascular Sciences, and former president and founder of the Indian Society of Hypertension, International College of Cardiology, and International College of Nutrition. He is the editor of the World Heart Journal and former professor of medicine at Subharti Medical College. He has contributed over 500 research papers to peer reviewed journals and has edited seven books.
Jan Fedacko, MD, PhD, FICC, FICN is Assistant Professor at Department of Medicine and Centre of Excellency for Atherosclerosis Research at Louis Pasteur University Hospital and Pavol Jozef Safarik University in Kosice, Slovak Republic. After obtaining a diploma in General Medicine of Pavol Jozef Safarik University in Kosice, Slovak Republic (2005) the Ph.D. study (negative pleiotropic effect of the statins and possibilities of its treatment) was completed in year 2010. He is member of executive board of International College of Cardiology, member of International College of Clinical Nutrition, Slovak Association of Cardiology, Slovak Association of Atherosclerosis and member of Editorial Advisory Board of several journals. In the clinical and research area he is focused on preventive cardiology, prevention and treatment of the atherosclerosis deseases, as well as in cardiac imagineg techniques. He has published several papers in domestic and international journals, including several international lectures.
Assoc. Prof. Dr. Krasimira Hristova is specialist cardiologist, expert of echocardiography at University National Heart Hospital, Sofia, Bulgaria and consulting cardiologist at Nadezhda Women’s Hospital , Sofia, Bulgaria . She earned a PhD in applying the newest echocardiographic methods for evaluating the myocardial deformation in patients, following acute m
  • Includes a number new and controversial topics: Pharmacological therapy; Gene therapy, Cell implantation, hormone replacement therapy; Therapy and management of arrhythmias, acute heart failure, paediatric heart failure; Invasive and surgical approaches to CHF; Non pharmalogical approaches such as dietary interventions, holistic approaches, and physical training; Updated guidelines from the International college of cardiology for management of heart failure
  • Includes never-published tables and figures to aid understanding of the topics
  • Contributions from international leading experts in the field, written with the aim of serving both researchers and practicing clinicians

Date de parution :

Ouvrage de 410 p.

21.4x27.6 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

Prix indicatif 159,65 €

Ajouter au panier

Ces ouvrages sont susceptibles de vous intéresser


The Kidney in Heart Failure 116,04 €

Device Therapy in Heart Failure 232,09 €

Pharmacologic Trends of Heart Failure 52,74 €